We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
(-20%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-12.69%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74
Top Buys
| 1 |
Quest Diagnostics
DGX
|
+$24.5M |
| 2 |
Church & Dwight Co
CHD
|
+$19.6M |
| 3 |
Eversource Energy
ES
|
+$18.2M |
| 4 |
Expedia Group
EXPE
|
+$17.6M |
| 5 |
Kimberly-Clark
KMB
|
+$17.5M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$31.2M |
| 2 |
Conagra Brands
CAG
|
+$27M |
| 3 |
SEE
Sealed Air
SEE
|
+$22.8M |
| 4 |
Eli Lilly
LLY
|
+$22.1M |
| 5 |
Regency Centers
REG
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 28% |
| 2 | Consumer Staples | 25.89% |
| 3 | Communication Services | 10.3% |
| 4 | Technology | 7.09% |
| 5 | Materials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Healthpeak Properties
DOC
$15.4B
| $86K | 0.01% |
3,310
+1,046
| +46% | +$31.7K |
|
|
CTLT
327
DELISTED
CATALENT, INC.
CTLT
| $86K | 0.01% |
805
| – | – |
|
328
Veeva Systems
VEEV
$31.8B
| $85K | 0.01% |
+430
| New | +$79.1K |
|
329
KeyCorp
KEY
$25.6B
| $83K | 0.01% |
+4,844
| New | +$93.6K |
|
330
Nasdaq
NDAQ
$51.8B
| $83K | 0.01% |
1,626
| – | – |
|
331
Teledyne Technologies
TDY
$29.4B
| $83K | 0.01% |
222
+98
| +79% | +$40.9K |
|
332
VF Corp
VFC
$6.65B
| $82K | 0.01% |
1,855
| – | – |
|
333
Boston Properties
BXP
$11.2B
| $81K | 0.01% |
914
+294
| +47% | +$32.5K |
|
334
Pool Corp
POOL
$7.47B
| $81K | 0.01% |
230
| – | – |
|
335
TransUnion
TRU
$15.3B
| $80K | 0.01% |
+1,001
| New | +$86.2K |
|
336
Camden Property Trust
CPT
$11.2B
| $76K | ﹤0.01% |
+567
| New | +$84K |
|
|
FRC
337
DELISTED
First Republic Bank
FRC
| $76K | ﹤0.01% |
+524
| New | +$78.5K |
|
338
CoStar Group
CSGP
$12.2B
| $73K | ﹤0.01% |
+1,212
| New | +$73.4K |
|
|
IPG
339
DELISTED
Interpublic Group of Companies
IPG
| $73K | ﹤0.01% |
2,669
+1,147
| +75% | +$36.4K |
|
340
VeriSign
VRSN
$25.1B
| $73K | ﹤0.01% |
+439
| New | +$80.5K |
|
341
LPL Financial
LPLA
$26.3B
| $71K | ﹤0.01% |
386
| – | – |
|
342
UDR
UDR
$13B
| $71K | ﹤0.01% |
1,543
| – | – |
|
343
Marvell Technology
MRVL
$171B
| $68K | ﹤0.01% |
1,561
| – | – |
|
344
Plug Power
PLUG
$3.06B
| $68K | ﹤0.01% |
+4,103
| New | +$81.4K |
|
345
Teradyne
TER
$50.4B
| $68K | ﹤0.01% |
756
| – | – |
|
346
Fair Isaac
FICO
$28.6B
| $67K | ﹤0.01% |
+166
| New | +$65.5K |
|
347
American Financial Group
AFG
$11.8B
| $66K | ﹤0.01% |
+472
| New | +$66.4K |
|
348
Broadcom
AVGO
$1.77T
| $66K | ﹤0.01% |
+1,350
| New | +$75.8K |
|
349
Teleflex
TFX
$5.99B
| $66K | ﹤0.01% |
+269
| New | +$78.4K |
|
350
Loews
L
$23.7B
| $65K | ﹤0.01% |
1,104
| – | – |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2022 Portfolio in Review
As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.
- TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
- TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
- TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
- TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
- TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
- TOBAM opened 74 new positions and closed 74 in Q2 2022.
- TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.
Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.